Cardiometabolic Disorders

Top Story

Exercise benefits outweigh negative effect of overweight, obesity on CVD risk

March 24, 2017

The benefits of physical activity on CVD may outweigh the negative impact of overweight and obesity in middle-aged and older adults, according to published data.

“Overweight and obesity is associated with a higher risk [for CVD] and it is recommended to lose weight,” Klodian Dhana, MD, PhD, a postdoctoral researcher in the department of epidemiology at Erasmus University Medical Centre in Rotterdam, Netherlands, said in a press release. “But in the elderly, this is slightly different because weight loss, especially unintentional, is associated with muscle loss and death. ... We investigated the combined impact of BMI and physical activity on [CVD] in middle age to elderly population.”

In the Journals

Type 1 diabetes associated with higher risk for ischemic, hemorrhagic stroke

March 23, 2017
Compared with the general population, patients with type 1 diabetes with or without maintaining target HbA1c levels were at increased risk for ischemic and hemorrhagic…
In the Journals PlusPerspective

Major abnormalities on ECG tied to CVD risk in type 1 diabetes

March 22, 2017
Major abnormalities on an electrocardiogram may be useful for predicting the development of cardiovascular disease in adults with type 1 diabetes, according to findings…
In the Journals Plus

Elevated white blood cell count in children may predict future insulin resistance

March 22, 2017
In Korean children, an increased white blood cell count may serve as a marker for insulin resistance independent of obesity, according to findings from a cross-sectional…
CME

Practical Lipidology®: Volume 3, Number 1

This activity is supported by an educational grant from Amgen

The reduction of low-density lipoprotein-cholesterol (LDL-C) is recognized as the primary strategy for decreasing…
More »
Video
Meeting News Coverage

VIDEO: Diabetes may be risk equivalent for PAD, CAS

April 3, 2016
More »
Featured
ObesityWeek

ObesityWeek

CME

Improving Bone Strength and Reducing Fracture Risk in Osteoporosis

This activity is supported by an educational grant from Merck & Co., Inc.

Osteoporosis is characterized by low bone mass and microarchitectural deterioration of bone tissue leading to reduced…
More »
In the Journals

Exercise benefits outweigh negative effect of overweight, obesity on CVD risk

March 24, 2017
The benefits of physical activity on CVD may outweigh the negative impact of overweight and obesity in middle-aged and older adults, according to…

In the Journals

Type 1 diabetes associated with higher risk for ischemic, hemorrhagic stroke

March 23, 2017
Compared with the general population, patients with type 1 diabetes with or without maintaining target HbA1c levels were at increased risk for…

In the Journals PlusPerspective

Major abnormalities on ECG tied to CVD risk in type 1 diabetes

March 22, 2017
Major abnormalities on an electrocardiogram may be useful for predicting the development of cardiovascular disease in adults with type 1 diabetes…

In the Journals Plus

Elevated white blood cell count in children may predict future insulin resistance

March 22, 2017
In Korean children, an increased white blood cell count may serve as a marker for insulin resistance independent of obesity, according to findings…

In the Journals Plus

NAFLD in type 1 diabetes associated with subclinical CVD risk

March 21, 2017
The prevalence of nonalcoholic fatty liver disease was found to be low in a small cohort of adults with type 1 diabetes, but those with nonalcoholic…

In the Journals Plus

Prepregnancy BMI, gestational diabetes related to metabolic syndrome risk

March 21, 2017
The risk for developing metabolic syndrome 7 years postpartum is increased among women with a higher prepregnancy BMI and early gestational diabetes…

Meeting NewsPerspective

EBBINGHAUS: Evolocumab does not affect cognitive outcomes

March 18, 2017
WASHINGTON — The addition of evolocumab to statin therapy did not result in memory loss or other cognitive issues, according to results of the…

Meeting NewsPerspective

Bococizumab yields varying effects on CV events, LDL in SPIRE trials

March 17, 2017
WASHINGTON — PCSK9 inhibition with bococizumab was safe in high-risk patients with LDL levels exceeding 100 mg/dL, but yielded mixed results on…

In the Journals Plus

Dual-therapy canagliflozin, phentermine reduces body weight in adults without diabetes

March 16, 2017
In adults with overweight or obesity but without diabetes, coadministration of canagliflozin and phentermine conferred greater weight loss at 26…

In the Journals Plus

Overweight, obesity increase cardiometabolic risk factor prevalence

March 15, 2017
The prevalence of cardiometabolic risk factors differs across weight classes with risk increasing among adults with overweight or obesity, but the…

More Headlines »
Advertisement
Advertisement